Quarterly report · Q1

Period2024-01-01 → 2024-03-31
Filed2024-05-09
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥740.3bn2024-01-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥2.84T2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥665.3bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Operating income¥215.8bn2024-01-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥206.4bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥201.3bn2024-01-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥621.6bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥183.1bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥157.3bn2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥482.3bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥144.7bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥157.8bn2024-01-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥485.3bn2023-01-01 → 2023-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥145.2bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥7.16Tat 2024-03-31Cons.Assets IFRS
Total assets¥7.28Tat 2023-12-31Cons.Assets IFRS
Total assets¥6.35Tat 2023-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.09Tat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥3.37Tat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥4.07Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥3.91Tat 2023-12-31Cons.Equity IFRS
Net assets / equity¥3.59Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥3.62Tat 2022-12-31dCons.Equity IFRS
Equity (owners)¥3.99Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.83Tat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥766.9bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.04Tat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥665.2bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥866.9bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥61.8bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥567.0bn2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥55.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥27.7bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥126.1bn2023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥41.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥341.2bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥270.5bn2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥196.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥88.582024-01-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥271.692023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥81.522023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥88.572024-01-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥271.632023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥81.492023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio55.7%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio52.6%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio55.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-03-31¥1.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-03-31¥322m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-03-31¥705m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥11.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥11.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥9.3bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-03-31−¥774m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-03-31−¥774m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-03-31¥23.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-03-31¥23.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2024-01-01 → 2024-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2024-01-01 → 2024-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥6m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2024-01-01 → 2024-03-31¥681.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2024-01-01 → 2024-03-31¥681.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥64m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥231.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥231.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥219.2bn
—segment totalrevenue2024-01-01 → 2024-03-31¥740.1bn
—segment totalrevenue external2024-01-01 → 2024-03-31¥740.0bn
—segment totalrevenue intersegment2024-01-01 → 2024-03-31¥69m
—segment totalsegment profit2024-01-01 → 2024-03-31¥237.7bn
—segment totalsegment profit2024-01-01 → 2024-03-31¥237.7bn
—segment totalsegment profit2024-01-01 → 2024-03-31¥225.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-03-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-03-31¥443m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥654m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.6bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2023-01-01 → 2023-03-31¥604.4bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2023-01-01 → 2023-03-31¥604.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥61m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥208.8bn
—segment totalrevenue2023-01-01 → 2023-03-31¥664.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥664.8bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥69m
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥217.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 891
ItemContextValueUnit
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-64000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember64000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration-JPY
Other ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-JPY
Other ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-JPY
Other ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-703000000JPY
Other ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-JPY
Other ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-703000000JPY
Other ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-JPY
Other ss IFRSCurrentYTDDuration-703000000JPY
Total transactions with owners IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-64000000JPY
Total transactions with owners IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-808000000JPY
Total transactions with owners IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-177525000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-178294000000JPY
Total transactions with owners IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-743000000JPY
Total transactions with owners IFRSCurrentYTDDuration-179037000000JPY
Equity IFRSCurrentQuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember11206000000JPY
Equity IFRSCurrentQuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember-JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember470118000000JPY
Equity IFRSCurrentQuarterInstant_RetainedEarningsIFRSMember3172063000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember3989504000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember82966000000JPY
Equity IFRSCurrentQuarterInstant4072470000000JPY
Profit loss before tax IFRSPrior1YTDDuration183146000000JPY
Profit loss before tax IFRSCurrentYTDDuration201266000000JPY
Depreciation and amortization ope cf IFRSPrior1YTDDuration42230000000JPY
Depreciation and amortization ope cf IFRSCurrentYTDDuration43965000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration756000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration190000000JPY
Interest and dividend income ope cf IFRSPrior1YTDDuration-7479000000JPY
Interest and dividend income ope cf IFRSCurrentYTDDuration-14231000000JPY
Interest expenses ope cf IFRSPrior1YTDDuration6811000000JPY
Interest expenses ope cf IFRSCurrentYTDDuration7477000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration-1299000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration-2073000000JPY
Gains losses on sale and disposal of property plant and equipment intangible assets and investment property ope cf IFRSPrior1YTDDuration59000000JPY
Gains losses on sale and disposal of property plant and equipment intangible assets and investment property ope cf IFRSCurrentYTDDuration-1829000000JPY
Decrease increase in trade and other receivables ope cf IFRSPrior1YTDDuration6099000000JPY
Decrease increase in trade and other receivables ope cf IFRSCurrentYTDDuration-19610000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration-14370000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-10873000000JPY
Increase decrease in trade and other payables ope cf IFRSPrior1YTDDuration-62781000000JPY
Increase decrease in trade and other payables ope cf IFRSCurrentYTDDuration-80986000000JPY
Increase decrease in retirement benefit liability ope cf IFRSPrior1YTDDuration-5529000000JPY
Increase decrease in retirement benefit liability ope cf IFRSCurrentYTDDuration-12259000000JPY
Increase decrease in prepaid tobacco excise taxes ope cf IFRSPrior1YTDDuration11639000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass